検索結果は2件です。

Treatment of advanced HCC with macro-vascular invasion (Surgery vs Sorafenib)

T. M.　Pawlik（Johns Hopkins Hospital）
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. Although several factors contribute to the poor prognosis associated with HCC, major vascular invasion is one of the mo...

第55回日本消化器病学会大会 ＞ JDDW International Debate Session　「Treatment of advanced HCC with macro-vascular invasion　（Surgery vs Sorafenib）」

Treatment of advanced HCC with macro-vascular invasion　（Surgery vs Sorafenib）

V.　Mazzaferro（Gastrointestinal Surgery and Liver Transplant Unit, Fondazione IRCCS Istituto Nazionale Tumori di Milano）
...

第55回日本消化器病学会大会 ＞ JDDW International Debate Session　「Treatment of advanced HCC with macro-vascular invasion　（Surgery vs Sorafenib）」